Home/Recalls/FDA-D-0551-2026
FDA DrugsClass III

PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Steril...

Published: June 3, 2026Recall ID: D-0551-2026Category: drugsCountry: US

Reason for Recall / Hazard

Failed Stability Specifications

Product Description & Identification

PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.

Additional Source Details

FieldValue
CityNorth Chicago
StateIL
Openfda › Upc0311980174101
Openfda › Unii8B2807733D
Openfda › RouteOPHTHALMIC
Openfda › Rxcui › 1209002
Openfda › Rxcui › 2562379
Openfda › Spl id02594e74-d6cf-40b5-bfb1-c27be33e0e35
Openfda › Brand namePRED MILD
Openfda › Spl set id4fcce64a-94ea-4031-ad5a-c4eddc73a910
Openfda › Package ndc › 111980-174-05
Openfda › Package ndc › 211980-174-10
Openfda › Product ndc11980-174
Openfda › Generic namePREDNISOLONE ACETATE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance namePREDNISOLONE ACETATE
Openfda › Manufacturer nameAllergan, Inc.
Openfda › Application numberNDA017100
Openfda › Is original packagertrue
Event id99008
Address 11 N Waukegan Rd
Code infoLot # 402805, 407596, Exp Date: 08/2026.
Postal code60064-1802
Report date20260603
Product typeDrugs
Product quantity2,736 bottles
Reason for recallFailed Stability Specifications
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260518
Initial firm notificationLetter
Center classification date20260527

Overview

  • Recalling FirmAbbVie Inc.
  • StatusOngoing
  • Risk LevelClass III
  • DistributionUS Nationwide.
Official Agency Alert